Please note that this content was created in 2018. In the time since this material was posted, there may have been additional developments, advancements, and/or more current publications in this field.
AMP Education is constantly updating our educational offerings, and will remove or replace content that is no longer accurate. Please be sure to use the search function to find related or updated material available in our catalogue at educate.amp.org. The Training and Education Committee works with AMP Education Programs to bring you the most up-to-date and cutting-edge information on molecular pathology research, applications, and training.
This is a recording of a session from the AMP 2018 Annual Meeting & Expo. Purchase the entire AMP Annual Meeting & Expo 2018 Recordings for a significant discount!
Human cancers are highly diverse, as evidenced by the complex pathologic classification systems that have evolved over the last century. Efforts to understand the genomics of solid tumors have only emphasized the complexity and demonstrated the biologic diversity of tumors even within individual morphologic categories. This results in significant implications for response to therapy and patient prognosis. This session will examine the genomic underpinnings of difficult-to-treat cancer types and will explore approaches to applying this knowledge to treatment selection.
Predictor of Response to PARP Inhibitors
Elizabeth M. Swisher, MD, University of Washington, Seattle, WA, USA
Leveraging Personalized Medicine for Diagnosis and Treatment of Pancreatic Cancer
Brian Wolpin, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, USA
Objectives:
- Examine the impact of germline cancer predisposition variants on therapeutic decision making and patient counseling.
- Describe the affect of common driver variants on the outcomes of patients with pancreatic cancer.
- Explain the current role of in vitro models of human cancer in individualized patient care.
- Recognize the significance of the BRCA-Fanconi anemia pathway in carcinogenesis and targeted therapeutics.
Duration: 1.50 hr
Recording Date: November 2, 2018
Last day to purchase: December 31, 2021
There are no CME/CMLE or SAMs credits available.Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
